J Allergy Clin Immunol. 2025 Dec 10:S0091-6749(25)01180-7. doi: 10.1016/j.jaci.2025.11.008. Online ahead of print. ABSTRACT BACKGROUND: Limited research exists on when […]
… rheumatology, department of internal medicine at Uijeongbu Eulji Medical Center, Eulji University School of Medicine in South Korea, and
Abstract Objectives Patient education is increasingly acknowledged as an important aspect of the management of systemic lupus erythematosus (SLE). The
Abstract Objective To assess efficacy of voclosporin from a retrospective, observational, clinical-practice-based, nationwide multicentre study of patients with lupus nephritis
Proc Natl Acad Sci U S A. 2025 Dec 16;122(50):e2507422122. doi: 10.1073/pnas.2507422122. Epub 2025 Dec 12. ABSTRACT Lupus nephritis (LN),
Cell Rep. 2025 Dec 11;44(12):116680. doi: 10.1016/j.celrep.2025.116680. Online ahead of print. ABSTRACT Immunotherapy has revolutionized cancer treatment, but it lacks
PLoS One. 2025 Dec 12;20(12):e0338378. doi: 10.1371/journal.pone.0338378. eCollection 2025. ABSTRACT BACKGROUND: Currently, the relationship between socioeconomic status (SES) and trabecular
Rheumatology (Oxford). 2025 Dec 12:keaf666. doi: 10.1093/rheumatology/keaf666. Online ahead of print. NO ABSTRACT PMID:41385293 | DOI:10.1093/rheumatology/keaf666
Rheumatology (Oxford). 2025 Dec 12:keaf651. doi: 10.1093/rheumatology/keaf651. Online ahead of print. ABSTRACT OBJECTIVES: This study aimed to estimate the incidence
Rheumatology (Oxford). 2025 Dec 12:keaf653. doi: 10.1093/rheumatology/keaf653. Online ahead of print. ABSTRACT OBJECTIVES: To assess the prevalence and factors associated
Rheumatology (Oxford). 2025 Dec 12:keaf659. doi: 10.1093/rheumatology/keaf659. Online ahead of print. ABSTRACT OBJECTIVES: Pulmonary manifestations of connective tissue diseases (CTDs)
Evaluation of Rheumatic Complaints https://t.co/dZjD1Y5IBn https://t.co/WwhMbUysZl https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 12/12/2025 – 20:00 RheumNow Dr. John Cush Evaluation of Rheumatic Complaints
Arti Mahto, Rheumatology, 2018. 2373 Anti-LGI1 associated myopathy in setting of neuromuscular hyperexcitability syndrome. Peter Anderyas, BMJÂ …
Cases & Guidelines: Tuesday Night Rheumatology Panelists discuss their approaches to a range of difficult cases in https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,
Indian J Ophthalmol. 2025 Dec 12. doi: 10.4103/IJO.IJO_676_25. Online ahead of print. ABSTRACT BACKGROUND: This study aimed to evaluate the
Z Rheumatol. 2025 Dec 12. doi: 10.1007/s00393-025-01762-5. Online ahead of print. ABSTRACT Protocols concerning classification, monitoring and treatment were developed
Adv Health Sci Educ Theory Pract. 2025 Dec 12. doi: 10.1007/s10459-025-10493-w. Online ahead of print. ABSTRACT Assessing clinical reasoning is
Biomech Model Mechanobiol. 2025 Dec 12;25(1):2. doi: 10.1007/s10237-025-02027-5. ABSTRACT Osteoarthritis induces profound structural degeneration of articular cartilage, with existing treatments
Rheumatology (Oxford). 2025 Nov 27:keaf628. doi: 10.1093/rheumatology/keaf628. Online ahead of print. ABSTRACT OBJECTIVES: The neural mechanisms underlying salience network (SN)
Mod Rheumatol. 2025 Dec 12:roaf122. doi: 10.1093/mr/roaf122. Online ahead of print. ABSTRACT OBJECTIVE: This study aimed to characterize patterns of
Mod Rheumatol. 2025 Dec 12:roaf123. doi: 10.1093/mr/roaf123. Online ahead of print. ABSTRACT OBJECTIVE: We aimed to follow patients classified as
Mod Rheumatol. 2025 Dec 12:roaf124. doi: 10.1093/mr/roaf124. Online ahead of print. ABSTRACT OBJECTIVES: To compare the efficacy and safety of
Disabil Rehabil Assist Technol. 2025 Dec 12:1-27. doi: 10.1080/17483107.2025.2591344. Online ahead of print. ABSTRACT PURPOSE: Employment determinants remain a critical
Int J Rheum Dis. 2025 Dec;28(12):e70505. doi: 10.1111/1756-185x.70505. NO ABSTRACT PMID:41384512 | DOI:10.1111/1756-185x.70505
Int J Rheum Dis. 2025 Dec;28(12):e70509. doi: 10.1111/1756-185x.70509. NO ABSTRACT PMID:41384532 | DOI:10.1111/1756-185x.70509
QD Clinic: Weakness with Fibromyalgia ack Cush, MD and Leilani Law, APN, Dallas, TX, discuss a case about weakness wit
The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized
